This study is looking at the genes of people with lung cancer and healthy individuals to understand how genetics might affect lung cancer risk and survival. Researchers are not testing any new drugs or treatments. They are studying how genetic differences (SNPs) are linked to lung cancer and how these differences might impact how well treatments work at various stages of the disease. The goal is to find factors that can predict how the disease will progress and how long people will live. You can join if you are 18 or older and either have lung cancer confirmed by a doctor or are a healthy person without any cancer. The study aims to enroll 15,000 participants. The current recruitment status is unclear.

Study design

This is an observational study with a case-control design, meaning researchers will compare people with lung cancer to healthy individuals. It plans to include 15,000 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Participants' survival will be monitored for 20 years using questionnaires and medical records.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.